The Most Disruptive and Compelling Automated Biology Companies of 2020

Automated Biology Companies Driving Massive R&D Efficiency Gains

High Throughput Experimentation (HTE) in the modern biology lab is as critical as in any other aspect of R&D, as well as absolutely essential to improve productivity in drug discovery. HTE Biology brings quality, automation and biological and technical innovation as the underpins of plurality and speed in modern drug discovery. This concept applies to assay development and screening systems, biochemical and cell-based assays, detection technologies (e.g., qRT-PCR, flow cytometry, immunoassays, high content imaging) and much more. Among exciting new technologies, gene editing, cellular engineering and synthetic biology emerge to the top as drivers of innovation and change in the way we do drug discovery and development. This webinar will feature four companies that are disrupting the way we do biology with outstanding innovative technologies and solutions. Come and hear about what Berkeley Lights, HiRes Biosolutions, Kytopen, and Synthace, are doing to bring the Lab of the Future to reality via lab automation, computer-aided biology, robotics, synthetic biology, cell engineering, new technologies to develop cell-based therapies, and more.

02:04:00